Viewing Study NCT04627402


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-26 @ 2:22 AM
Study NCT ID: NCT04627402
Status: UNKNOWN
Last Update Posted: 2020-11-17
First Post: 2020-10-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-12
Start Date Type: ACTUAL
Primary Completion Date: 2021-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2020-10-29
First Submit QC Date: None
Study First Post Date: 2020-11-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-14
Last Update Post Date: 2020-11-17
Last Update Post Date Type: ACTUAL